Pavadi Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$7.56M Buy
27,927
+12,216
+78% +$3.02M 9.31% 3
2023
Q3
$3.86M Buy
15,711
+333
+2% +$91.1K 5.03% 13
2023
Q2
$4.67M Sell
15,378
-2,646
-15% -$736K 5.44% 12
2023
Q1
$4.75M Sell
18,024
-9,576
-35% -$2.43M 5.19% 12
2022
Q4
$6.62M Buy
27,600
+4,805
+21% +$1.08M 6.24% 3
2022
Q3
$4.19M Buy
22,795
+4,815
+27% +$959K 4.01% 14
2022
Q2
$3.02M Buy
17,980
+2,860
+19% +$614K 2.74% 22
2022
Q1
$3.79M Sell
15,120
-2,321
-13% -$583K 3.34% 18
2021
Q4
$4.48M Buy
+17,441
New +$4.27M 3.4% 19

Other funds holding HCA

Pavadi Capital's HCA Position: Q4 2023 in Review

Pavadi Capital increased its HCA Healthcare (HCA) stake by 78% in Q4 2023, buying an estimated $3.02M and bringing the position to 27,927 shares worth $7.56M. The position accounts for 9.31% of the portfolio, ranked #3.

Pavadi Capital first reported a position in HCA in Q4 2021 and has held it in 9 quarters since. 1,057 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Pavadi Capital held 27,927 shares of HCA Healthcare worth $7.56M as of Q4 2023.
  • Pavadi Capital bought 12,216 HCA Healthcare shares in Q4 2023, an estimated $3.02M.
  • HCA Healthcare made up 9.31% of Pavadi Capital's portfolio in Q4 2023, its #3 holding.
  • Pavadi Capital first reported a position in HCA Healthcare in Q4 2021 and has held it in 9 quarters since.
  • 1,057 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.